Chinese Journal of Lung Cancer
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.3779/j.issn.1009-3419.2016.10.08&title=厄洛替尼治疗34例肺鳞癌患者的疗效观察&author=&keyword=[{keywordId=2472, uniqueName=lung-neoplasms, name=Lung neoplasms, contentId=5621}, {keywordId=3003, uniqueName=厄洛替尼, name=厄洛替尼, contentId=5621}, {keywordId=3325, uniqueName=肺鳞癌, name=肺鳞癌, contentId=5621}, {keywordId=3497, uniqueName=egfr-tki, name=EGFR-TKI, contentId=5621}, {keywordId=3498, uniqueName=erlotinib, last=true, name=Erlotinib, contentId=5621}],[{keywordId=2472, uniqueName=lung-neoplasms, name=Lung neoplasms, contentId=5621}, {keywordId=3003, uniqueName=厄洛替尼, name=厄洛替尼, contentId=5621}, {keywordId=3325, uniqueName=肺鳞癌, name=肺鳞癌, contentId=5621}, {keywordId=3497, uniqueName=egfr-tki, name=EGFR-TKI, contentId=5621}, {keywordId=3498, uniqueName=erlotinib, last=true, name=Erlotinib, contentId=5621}],[{keywordId=2472, uniqueName=lung-neoplasms, name=Lung neoplasms, contentId=5621}, {keywordId=3003, uniqueName=厄洛替尼, name=厄洛替尼, contentId=5621}, {keywordId=3325, uniqueName=肺鳞癌, name=肺鳞癌, contentId=5621}, {keywordId=3497, uniqueName=egfr-tki, name=EGFR-TKI, contentId=5621}, {keywordId=3498, uniqueName=erlotinib, last=true, name=Erlotinib, contentId=5621}],[{keywordId=2472, uniqueName=lung-neoplasms, name=Lung neoplasms, contentId=5621}, {keywordId=3003, uniqueName=厄洛替尼, name=厄洛替尼, contentId=5621}, {keywordId=3325, uniqueName=肺鳞癌, name=肺鳞癌, contentId=5621}, {keywordId=3497, uniqueName=egfr-tki, name=EGFR-TKI, contentId=5621}, {keywordId=3498, uniqueName=erlotinib, last=true, name=Erlotinib, contentId=5621}],[{keywordId=2472, uniqueName=lung-neoplasms, name=Lung neoplasms, contentId=5621}, {keywordId=3003, uniqueName=厄洛替尼, name=厄洛替尼, contentId=5621}, {keywordId=3325, uniqueName=肺鳞癌, name=肺鳞癌, contentId=5621}, {keywordId=3497, uniqueName=egfr-tki, name=EGFR-TKI, contentId=5621}, {keywordId=3498, uniqueName=erlotinib, last=true, name=Erlotinib, contentId=5621}],&subject=